Basel Medical ratios data for the quarter ended Dec 2025. These financial ratios cover 5 quarters of results from Dec 2023 through Dec 2025, standardized by Business Quant from the company’s SEC filings.
| Ratios | Dec2023 | Jun2024 | Dec2024 | Jun2025 | Dec2025 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBT Margin | 38.09% | ||||
| EBIT Margin | 36.20% | ||||
| EBITDA Margin | 30.99% | ||||
| Net Margin | 50.11% | ||||
| FCF Margin | 0.16% | ||||
| Efficiency | |||||
| Inventory AverageInventory Avg. | 0.08M | 0.24M | 0.32M | ||
| Assets AverageAssets Avg. | 13.49M | 14.64M | 14.94M | ||
| Invested CapitalInvested Cap. | 10.78M | 9.71M | 12.85M | ||
| Leverage & Solvency | |||||
| Interest Coverage RatioInterest Cover | -19.16 | -2.24 | |||
| Debt Ratio | 0.43 | 0.62 | 0.39 | 0.50 | |
| Times Interest Earned | -19.16 | -2.24 | |||
| Valuation | |||||
| Price to EarningsP/E | 1.10 | ||||
| Price to SalesP/S | 8.14 | ||||
| Price to BookP/B | 0.67 | 0.15 | |||
| Enterprise Value | 0.45M | -0.02M | |||
| Market Capitalization | 2.79M | 0.77M | |||
| Return Ratios | |||||
| Return on Sales [ROS]ROS | 36.20% |